Cellectis to Participate in Oppenheimer Life Sciences Summit, NY & in Piper Jaffray 28th Annual Health Care Conference, NY
Published on November 21, 2016
November 21, 2016 – New York (N.Y.) – Cellectis (Alternext: ALCLS; Nasdaq: CLLS), a biopharmaceutical company focused on developing immunotherapies based on gene edited CAR T-cells (UCART), today announced that the Company will participate in the upcoming Oppenheimer Life Sciences Summit being held on November 29, 2016 at the Sofitel Hotel in New York City.
Cellectis will be presenting at the Piper Jaffray 28th Annual Health Care Conference. Cellectis presentation will take place on November 30, 2016 at 8:00AM US Eastern Time in Lotte New York Palace - 455 Madison Ave, Track Three - Holmes 1 - 4th Floor.
A live webcast will be available at http://edge.media-server.com/m/p/xbcsg2nz
The replay is available via the same link.